We Need a Better Way Of Distributing the COVID-19 Vaccine. Here’s How To Do It.
In an op-ed for The Washington Post, KFF President Drew Altman calls for a simplification of the troubled COVID-19 vaccine distribution system.
View the Latest: Vaccines
Filter
-
-
The Challenge Of Vaccine Hesitancy In Rural America
From Drew AltmanIn his latest Axios column, Drew Altman looks at the challenge of vaccine hesitancy in rural America and its implications. One of them: a highly tailored outreach campaign is needed. “Addressing this hesitancy will require convincing rural Americans about the seriousness of the pandemic, and then that the vaccine is a way to protect them, their families and their way of life,” he said.
-
The COVID-19 “Vaccination Line”: An Update on State Prioritization Plans
Issue BriefThis analysis examines the different approaches states are taking to manage the limited initial supply of COVID-19 vaccines and balance the desire to vaccinate those at greatest risk first with the need to ensure a fast and effective statewide vaccination effort. It includes a state data table.
-
New Analysis Takes In-Depth Look at How States are Prioritizing Who Gets a COVID-19 Vaccine
News ReleaseA new KFF analysis examines the different approaches states are taking to manage the limited initial supply of COVID-19 vaccines and balance the desire to vaccinate those at greatest risk first with the need to ensure a fast and effective statewide vaccination effort. Based on a review of state vaccination plans, the analysis finds that states are increasingly departing from the Centers for Disease Control and Prevention’s recommendations as they move through the first three…
-
Analysis: Rural Residents Stand Out as One of the Most Hesitant Groups to Get a COVID-19 Vaccine and Pose Special Challenges for the Mass Vaccination Efforts
News ReleaseA new analysis of KFF COVID-19 Vaccine Monitor survey data finds that residents of rural America stand out as one of the groups most hesitant to get a COVID-19 vaccine and that their views about the pandemic could pose significant challenges for the nation’s mass vaccination effort. About a third (35%) of people living in rural areas say they probably or definitely would not get a COVID-19 vaccine that had been deemed safe and effective…
-
Vaccine Hesitancy in Rural America
Poll FindingBased on data from the KFF COVID-19 Vaccine Monitor, this poll finding explores attitudes among rural Americans toward the coronavirus and willingness to get a potential vaccine.
-
Federal Rules Protect People from Bills for the COVID-19 Vaccine
News ReleaseAs the first doses of the new COVID-19 vaccine are delivered to health care workers and other early recipients, many Americans are eager to know not only when the vaccine will be available to them but also whether they will be able to get it at no cost. The answer is that providers are not allowed to charge patients who get the vaccine, at least during the public health emergency, KFF experts write in a…
-
Gaps in Cost Sharing Protections for COVID-19 Testing and Treatment Could Spark Public Concerns About COVID-19 Vaccine Costs
Issue BriefIn the issue brief, KFF experts highlight the laws and regulations that are in place to ensure access to free COVID-19 vaccines for individuals regardless of their insurance status and explain how vaccine administration costs will be covered in private insurance, Medicare and Medicaid, and for the uninsured.
-
How are States Prioritizing Who Will Get the COVID-19 Vaccine First?
News ReleaseThe first Americans were vaccinated today as COVID-19 vaccines are being distributed across the country. A new KFF review of states’ releases and statements about their vaccination priorities finds that most states are following the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices recommendations for the highest priority group (health care workers and long-term care residents), with some choosing to start with one of the populations in the first weeks as…
-
Real Progress Is Possible On Vaccine Hesitancy
From Drew AltmanDrew Altman’s Axios column draws on data from the new KFF COVID-19 Vaccine Monitor to assess where the country stands on vaccine hesitancy.